Mark Gaffney
Chief Executive Officer at Oxular Ltd.
Profile
Mark W.
S.
Gaffney is currently the Chief Executive Officer & Director at Oxular Ltd.
He was previously the Director at Virtual Software Systems, Inc. from 2016 to 2017.
He also held the position of Chief Operating & Business Officer at Vedere Bio II, Inc. Mr. Gaffney completed his undergraduate degree at the University of Pennsylvania and his graduate degree at Boston University.
Mark Gaffney active positions
Companies | Position | Start |
---|---|---|
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Chief Executive Officer | 10/09/2023 |
Former positions of Mark Gaffney
Companies | Position | End |
---|---|---|
Virtual Software Systems, Inc.
Virtual Software Systems, Inc. Packaged SoftwareTechnology Services Virtual Software Systems, Inc. develops a software platform to provide protection for data and applications running in public, private, and hybrid clouds on bare metal or embedded systems. The company was founded in 2014 and is headquartered in Burlington, MA. | Director/Board Member | 31/08/2017 |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Chief Operating Officer | - |
Training of Mark Gaffney
University of Pennsylvania | Undergraduate Degree |
Boston University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Virtual Software Systems, Inc.
Virtual Software Systems, Inc. Packaged SoftwareTechnology Services Virtual Software Systems, Inc. develops a software platform to provide protection for data and applications running in public, private, and hybrid clouds on bare metal or embedded systems. The company was founded in 2014 and is headquartered in Burlington, MA. | Technology Services |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Commercial Services |
- Stock Market
- Insiders
- Mark Gaffney